ES2149471T3 - Compuesto con glicolato de almidon sodico como material soporte y productos a base de dicho compuesto. - Google Patents
Compuesto con glicolato de almidon sodico como material soporte y productos a base de dicho compuesto.Info
- Publication number
- ES2149471T3 ES2149471T3 ES96913671T ES96913671T ES2149471T3 ES 2149471 T3 ES2149471 T3 ES 2149471T3 ES 96913671 T ES96913671 T ES 96913671T ES 96913671 T ES96913671 T ES 96913671T ES 2149471 T3 ES2149471 T3 ES 2149471T3
- Authority
- ES
- Spain
- Prior art keywords
- sodium starch
- starch glycolate
- active substances
- support material
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE PREPARAN COMPOSICIONES ACTIVADAS MECANICAMENTE QUE INCLUYEN SUSTANCIAS FARMACEUTICAMENTE ACTIVAS Y GLICOLATO SODICO DE ALMIDON COMO MATERIAL DE SOPORTE MEDIANTE LA CO ON DE ELEVADA ENERGIA DE LAS SUSTANCIAS FARMACEUTICAMENTE ACTIVAS Y EL GLICOLATO SODICO DE ALMIDON PARA OBTENER LAS COMPOSICIONES ACTIVADAS MECANICAMENTE QUE POSEEN VELOCIDADES AUMENTADAS DE DISOLUCION, CINETICAS MEJORADAS DE SOLUBILIZACION, BIODISPONIBILIDAD MEJORADA, Y NIVELES PICO MEJORADOS DE FARMACO EN PLASMA DE LAS SUSTANCIAS FARMACEUTICAMENTE ACTIVAS CUANDO SE COMPARAN CON LAS SUSTANCIAS ACTIVAS PER SE O CON FORMULACIONES CONOCIDAS DE LAS MISMAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42543495A | 1995-04-20 | 1995-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2149471T3 true ES2149471T3 (es) | 2000-11-01 |
Family
ID=23686568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96913671T Expired - Lifetime ES2149471T3 (es) | 1995-04-20 | 1996-04-17 | Compuesto con glicolato de almidon sodico como material soporte y productos a base de dicho compuesto. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0822808B1 (es) |
JP (1) | JPH11503749A (es) |
AT (1) | ATE194909T1 (es) |
AU (1) | AU5658496A (es) |
CA (1) | CA2218486A1 (es) |
DE (1) | DE69609501T2 (es) |
DK (1) | DK0822808T3 (es) |
ES (1) | ES2149471T3 (es) |
GR (1) | GR3034617T3 (es) |
PT (1) | PT822808E (es) |
WO (1) | WO1996032931A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1295289B1 (it) * | 1997-10-07 | 1999-05-04 | Telos S R L | Co-macinati per uso cosmetico e dermatologico |
ATE301499T1 (de) * | 2001-06-29 | 2005-08-15 | Eurand Pharmaceuticals Ltd | Verfahren zur arzneimittelaktivierung mittels schwingmühle |
EP1406728B1 (en) * | 2001-06-29 | 2004-11-03 | Eurand Pharmaceuticals Ltd. | Process for activation of drugs in a vibrational mill |
RS20060035A (en) | 2003-07-22 | 2008-08-07 | Arena Pharmaceuticals Inc., | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物 |
JP5393677B2 (ja) | 2007-08-15 | 2014-01-22 | アリーナ ファーマシューティカルズ, インコーポレイテッド | 5−HT2Aセロトニン受容体に関連した障害の治療のための5−HT2Aセロトニン受容体のモジュレーターとしてのイミダゾ[1,2−a]ピリジン誘導体 |
WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
EP2364142B1 (en) | 2008-10-28 | 2018-01-17 | Arena Pharmaceuticals, Inc. | Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto |
WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
ITMI20120092A1 (it) * | 2012-01-26 | 2013-07-27 | Micro Macinazione S A | Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia |
EP4119141A1 (en) | 2015-06-12 | 2023-01-18 | Axovant Sciences GmbH | Nelotanserin for the prophylaxis and treatment of rem sleep behavior disorder |
TW201720439A (zh) | 2015-07-15 | 2017-06-16 | Axovant Sciences Gmbh | 用於預防及治療與神經退化性疾病相關的幻覺之作為5-ht2a血清素受體的二芳基及芳基雜芳基脲衍生物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5132719A (en) * | 1974-09-13 | 1976-03-19 | Yoshinobu Nakai | Iyakuhinnoshorihoho |
GB8403359D0 (en) * | 1984-02-08 | 1984-03-14 | Erba Farmitalia | Pharmaceutical compositions |
IT1227626B (it) * | 1988-11-28 | 1991-04-23 | Vectorpharma Int | Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione |
US5130140A (en) * | 1989-09-14 | 1992-07-14 | Hoeschst-Roussel Pharmaceuticals Inc. | Method of making direct dry compressible acetaminophen composition |
-
1996
- 1996-04-17 EP EP96913671A patent/EP0822808B1/en not_active Expired - Lifetime
- 1996-04-17 AU AU56584/96A patent/AU5658496A/en not_active Abandoned
- 1996-04-17 DE DE69609501T patent/DE69609501T2/de not_active Expired - Lifetime
- 1996-04-17 WO PCT/IB1996/000492 patent/WO1996032931A2/en active IP Right Grant
- 1996-04-17 CA CA002218486A patent/CA2218486A1/en not_active Abandoned
- 1996-04-17 PT PT96913671T patent/PT822808E/pt unknown
- 1996-04-17 DK DK96913671T patent/DK0822808T3/da active
- 1996-04-17 ES ES96913671T patent/ES2149471T3/es not_active Expired - Lifetime
- 1996-04-17 JP JP8531596A patent/JPH11503749A/ja not_active Ceased
- 1996-04-17 AT AT96913671T patent/ATE194909T1/de active
-
2000
- 2000-10-12 GR GR20000402302T patent/GR3034617T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0822808B1 (en) | 2000-07-26 |
DE69609501D1 (de) | 2000-08-31 |
DK0822808T3 (da) | 2000-10-09 |
PT822808E (pt) | 2000-12-29 |
WO1996032931A3 (en) | 1996-11-28 |
CA2218486A1 (en) | 1996-10-24 |
EP0822808A2 (en) | 1998-02-11 |
AU5658496A (en) | 1996-11-07 |
JPH11503749A (ja) | 1999-03-30 |
GR3034617T3 (en) | 2001-01-31 |
DE69609501T2 (de) | 2001-03-29 |
WO1996032931A2 (en) | 1996-10-24 |
ATE194909T1 (de) | 2000-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2149471T3 (es) | Compuesto con glicolato de almidon sodico como material soporte y productos a base de dicho compuesto. | |
UY24875A1 (es) | Composiciones farmacéuticas conteniendo tetrahidrolipstatina | |
YU10699A (sh) | Upotreba glp-1, glp-1 analoga i glp-1 derivata za proizvodnju leka | |
NO20002786L (no) | Adamantanderivater | |
AU7915898A (en) | Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration | |
PT840603E (pt) | Composicao farmaceutica a base de ester etilico de levo-dopa | |
BG103862A (en) | Compositions of derivatives of erythromycin with continuous release | |
AU7001001A (en) | Modified forms of pharmacologically active agents and uses therefor | |
AU2982889A (en) | Novel dosage form of fenofibrate | |
RS20090086A (en) | Nucleoside analogs with carobxamidine modified monocyclic base | |
BG103714A (en) | Pararacetamol-containing tablet | |
GR1003530B (el) | Ταχεως διαλυομενες συνθεσεις εχουσες αναλγητικη δραση | |
AU2265701A (en) | Anti-hiv-1 conjugates for treatment of hiv disease | |
DE69433355D1 (de) | Taxane ohne die c-9 oxo gruppe und diese enthaltende pharmazeutische präparate | |
EP1219596A4 (en) | Salicylamide DERIVATIVES | |
FR2735369B1 (fr) | Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside | |
ITMI20022292A1 (it) | 9a-azalidi ad attivita' antiinfiammatoria. | |
AU2002215904A1 (en) | Compounds with a branched linker | |
IL150528A0 (en) | Ibuprofen containing active agent preparation | |
CA2350659A1 (en) | Pharmaceutical composition for modified release insulin sensitiser | |
IT1301968B1 (it) | Derivati di eritromicina ad attivita' antibiotica | |
NZ515999A (en) | Biologically active materials | |
MXPA01008348A (es) | Microcapsulas para la liberacion prolongada de farmacos. | |
AU5685300A (en) | Solid preparations containing paroxetine | |
PL1499278T3 (pl) | Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 822808 Country of ref document: ES |